Skip to main content
SpringerLink
Log in

Targeting of Memory

  • Conference paper
  • First Online:
Immunotherapy in 2020

Part of the book series: Ernst Schering Foundation Symposium Proceedings ((SCHERING FOUND,volume 2006/4))

  • 702 Accesses

Abstract

Current therapeutic options that are based on immunosuppression do not provide a cure for the treatment of chronic inflammation. Though more efficient immunosuppression and the introduction of biologicals such as antibodies targeting cytokines have improved clinical outcomes, immunosuppressive therapy has to be continued to be efficient, thus enhancing the risk of adverse events and undesired side effects. Why can immunosuppression ameliorate, even stop, but not cure chronic inflammation? Is chronic inflammation perpetuated beyond suppression by mechanisms independent of the immune system, or is it perpetuated by components of the immune system which are resistant to a block of ongoing immune reactions? One such component of the immune system is immunological memory. This article will review the role of immunological memory in chronic inflammation, as far as we understand it today, and discuss implications for the development of novel therapeutic strategies aiming at a cure for diseases involving chronic inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aarvak T, Chabaud M, Miossec P, Natvig JB (1999) IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 162:1246–1251

    CAS  PubMed  Google Scholar 

  • Bernasconi NL, Traggiai E, Lanzavecchia A (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199–2202

    Article  CAS  PubMed  Google Scholar 

  • Bernasconi NL, Onai N, Lanzavecchia A (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101:4500–4504

    Article  CAS  PubMed  Google Scholar 

  • Brennan FM, Foey AD, Feldmann M (2006) The importance of T cell interactions with macrophages in rheumatoid cytokine production. Curr Top Microbiol Immunol 305:177–194

    Article  CAS  PubMed  Google Scholar 

  • Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1:904–907

    Article  CAS  PubMed  Google Scholar 

  • Brinkmann V, Kristofic C (1995) Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO− and CD45RO+ subsets. J Immunol 155:3322–3328

    CAS  PubMed  Google Scholar 

  • Buttgereit F, Straub RH, Wehling M, Burmester GR (2004) Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum 50:3408–3417

    Article  CAS  PubMed  Google Scholar 

  • Calin A, Elswood J, Klouda PT (1989) Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. Arthritis Rheum 32:1221–1225

    Article  CAS  PubMed  Google Scholar 

  • Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M, Webster AD (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 48:2146–2154

    Article  PubMed  Google Scholar 

  • Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, Mostarac M, Muehlinghaus G, Szyska M, Radbruch A, Manz RA (2003) Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 171:1684–1690

    CAS  PubMed  Google Scholar 

  • Chan ES, Cronstein BN (2002) Molecular action of methotrexate in inflammatory diseases. Arthritis Res 4:266–273

    Article  PubMed  Google Scholar 

  • Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ (1999a) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189:1639–1648

    Article  CAS  PubMed  Google Scholar 

  • Chan OT, Madaio MP, Shlomchik MJ (1999b) B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 163:3592–3596

    CAS  PubMed  Google Scholar 

  • Chistiakov DA (2003) Thyroid-stimulating hormone receptor and its role in Graves' disease. Mol Genet Metab 80:377–388

    Article  CAS  PubMed  Google Scholar 

  • Choy EH, Pitzalis C, Cauli A, Bijl JA, Schantz A, Woody J, Kingsley GH, Panayi GS (1996) Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis Rheum 39:52–56

    Article  CAS  PubMed  Google Scholar 

  • Cohen SB (2004) The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis (review). Rheum Dis Clin North Am 30:365–380, vii

    Google Scholar 

  • Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group (2006) Rituximab for rheumatoid arthritis refractory to antitumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54:2793–2806

    Article  CAS  PubMed  Google Scholar 

  • Cope AP (2002) Studies of T-cell activation in chronic inflammation. Arthritis Res 4(3):S197–S211

    Article  PubMed  Google Scholar 

  • De Kleer IM, Brinkman DM, Ferster A, Abinun M, Quartier P, Van Der Net J, Ten Cate R, Wedderburn LR, Horneff G, Oppermann J, Zintl F, Foster HE, Prieur AM, Fasth A, Van Rossum MA, Kuis W, Wulffraat NM (2004) Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 63:1318–1326

    Article  PubMed  Google Scholar 

  • Di Rosa F, Pabst R (2005) The bone marrow: a nest for migratory memory T cells. Trends Immunol 26:360–366

    Article  PubMed  Google Scholar 

  • DiLorenzo TP, Serreze DV (2005) The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol Rev 204:250–263

    Article  CAS  PubMed  Google Scholar 

  • Dorner T, Hansen A (2004) Autoantibodies in normals—the value of predicting rheumatoid arthritis. Arthritis Res Ther 6:282–284

    Article  PubMed  Google Scholar 

  • Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797–1810

    Article  CAS  PubMed  Google Scholar 

  • Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572–2581

    Article  CAS  PubMed  Google Scholar 

  • Ehinger M, Vestberg M, Johansson AC, Johannesson M, Svensson A, Holmdahl R (2001) Influence of CD4 or CD8 deficiency on collagen-induced arthritis. Immunology 103:291–300

    Article  CAS  PubMed  Google Scholar 

  • Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz AJ, van Vollenhoven RF, Li NF, Agarwal S, Hessey EW, Shaw TM; DANCER Study Group (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 54:1390–1400

    Article  CAS  PubMed  Google Scholar 

  • Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N (1998) B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 161:1163–1168

    CAS  PubMed  Google Scholar 

  • Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Strand V, Kirschbaum BJ (1999) Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol 93:198–208

    Article  CAS  PubMed  Google Scholar 

  • Grayson JM, Harrington LE, Lanier JG, Wherry EJ, Ahmed R (2002) Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo. J Immunol 169:3760–3770

    CAS  PubMed  Google Scholar 

  • Horneff G, Burmester GR, Emmrich F, Kalden JR (1991) Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 34:129–140

    Article  CAS  PubMed  Google Scholar 

  • Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, Eilat D, Radbruch A, Hiepe F, Manz RA (2004) Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 199:1577–1584

    Article  CAS  PubMed  Google Scholar 

  • Iqbal N, Oliver JR, Wagner FH, Lazenby AS, Elson CO, Weaver CT (2002) T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J Exp Med 195:71–84

    Article  CAS  PubMed  Google Scholar 

  • Jayne D, Passweg J, Marmont A, et al. (2004) Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13:168–176

    Article  PubMed  Google Scholar 

  • Kalia V, Sarkar S, Gourley TS, Rouse BT, Ahmed R (2006) Differentiation of memory B and T cells. Curr Opin Immunol 18:255–264

    Article  CAS  PubMed  Google Scholar 

  • Keren DF, Kumar NB, Appelman HD (1987) Quantification of IgG-containing plasma cells as an adjunct to histopathology in distinguishing acute self-limited colitis from active idiopathic inflammatory bowel disease. Pathol Immunopathol Res 6:435–441

    Article  CAS  PubMed  Google Scholar 

  • Klareskog L, Alfredsson L, Rantapaa-Dahlqvist S, Berglin E, Stolt P, Padyukov L (2004) What precedes development of rheumatoid arthritis? Ann Rheum Dis 63(2):ii28–ii31

    Google Scholar 

  • Kohem CL, Brezinschek RI, Wisbey H, Tortorella C, Lipsky PE, Oppenheimer-Marks N (1996) Enrichment of differentiated CD45RBdim, CD27− memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 39:844–854

    Article  CAS  PubMed  Google Scholar 

  • Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467–476

    Article  CAS  PubMed  Google Scholar 

  • Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D (1999) From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10:451–461

    Article  CAS  PubMed  Google Scholar 

  • Lafaille JJ, Keere FV, Hsu AL, Baron JL, Haas W, Raine CS, Tonegawa S (1997) Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med 186:307–312

    Article  CAS  PubMed  Google Scholar 

  • Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–240

    Article  CAS  PubMed  Google Scholar 

  • Lanzavecchia A, Sallusto F (2005) Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 17:326–332

    Article  CAS  PubMed  Google Scholar 

  • Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, Christensen SR, Shlomchik MJ, Viglianti GA, Rifkin IR, Marshak-Rothstein A (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 202:1171–1177

    Article  CAS  PubMed  Google Scholar 

  • Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603–607

    Article  CAS  PubMed  Google Scholar 

  • Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA (2005) B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) 44:1542–1545

    Article  CAS  Google Scholar 

  • Lohning M, Richter A, Radbruch A (2002) Cytokine memory of T helper lymphocytes. Adv Immunol 80:115–181

    Article  CAS  PubMed  Google Scholar 

  • Lohning M, Hutloff A, Kallinich T, Mages HW, Bonhagen K, Radbruch A, Hamelmann E, Kroczek RA (2003) Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med 197:181–193

    Article  CAS  PubMed  Google Scholar 

  • Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS (2006) Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford) 46:342–349

    Article  Google Scholar 

  • Maffia P, Brewer JM, Gracie JA, Ianaro A, Leung BP, Mitchell PJ, Smith KM, McInnes IB, Garside P (2004) Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J Immunol 173:151–156

    CAS  PubMed  Google Scholar 

  • Miller JJ 3rd (1964) An autoradiographic study of plasma cell and lymphocyte survival in rat popliteal lymph nodes. J Immunol 92:673–681

    PubMed  Google Scholar 

  • Minges Wols HA, Underhill GH, Kansas GS, Witte PL (2002) The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J Immunol 169:4213–4221

    CAS  PubMed  Google Scholar 

  • Morita Y, Yamamura M, Kawashima M, Harada S, Tsuji K, Shibuya K, Maruyama K, Makino H (1998) Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 41:1669–1676

    Article  CAS  PubMed  Google Scholar 

  • Muehlinghaus G, Cigliano L, Huehn S, Peddinghaus A, Leyendeckers H, Hauser AE, Hiepe F, Radbruch A, Arce S, Manz RA (2005) Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 105:3965–3971

    Article  CAS  PubMed  Google Scholar 

  • Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R, Campbell C, Memon S, Nagle JW, Hakim FT, Gress RE, McFarland HF, Burt RK, Martin R (2005) Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 201:805–816

    Article  CAS  PubMed  Google Scholar 

  • Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957

    Article  CAS  PubMed  Google Scholar 

  • Nakajima C, Mukai T, Yamaguchi N, Morimoto Y, Park WR, Iwasaki M, Gao P, Ono S, Fujiwara H, Hamaoka T (2002) Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation. Eur J Immunol 32:1792–1801

    Article  CAS  PubMed  Google Scholar 

  • Nepom GT (2002) Therapy of autoimmune diseases: clinical trials and new biologics. Curr Opin Immunol 14:812–815

    Article  CAS  PubMed  Google Scholar 

  • Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T (2004) Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 50:1761–1769

    Article  CAS  PubMed  Google Scholar 

  • Orme IM (1988) Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 140:3589–3593

    CAS  PubMed  Google Scholar 

  • Panaccione R, Ferraz JG, Beck P (2005) Advances in medical therapy of inflammatory bowel disease. Curr Opin Pharmacol 5:566–572

    CAS  PubMed  Google Scholar 

  • Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T, Hiepe F (2006) Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6:741–750

    Article  CAS  PubMed  Google Scholar 

  • Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741–2749

    Article  PubMed  Google Scholar 

  • Roosnek E, Lanzavecchia A (1991) Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 173:487–489

    Article  CAS  PubMed  Google Scholar 

  • Rosen O, Thiel A, Massenkeil G, Hiepe F, Haupl T, Radtke H, Burmester GR, Gromnica-Ihle E, Radbruch A, Arnold R (2000) Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2:327–336

    Article  CAS  PubMed  Google Scholar 

  • Roth R, Nakamura T, Mamula MJ (1996) B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. J Immunol 157:2924–2931

    CAS  PubMed  Google Scholar 

  • Rotondi M, Lazzeri E, Romagnani P, Serio M (2003) Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 26:177–180

    CAS  PubMed  Google Scholar 

  • Schroder AE, Greiner A, Seyfert C, Berek C (1996) Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA 93:221–225

    Article  CAS  PubMed  Google Scholar 

  • Scott DL, Kingsley GH (2006) Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 355:704–712

    Article  CAS  PubMed  Google Scholar 

  • Slifka MK, Antia R, Whitmire JK, Ahmed R (1998) Humoral immunity due to long-lived plasma cells. Immunity 8:363–372

    Article  CAS  PubMed  Google Scholar 

  • Smedegard G, Bjork J (1995) Sulphasalazine: mechanism of action in rheumatoid arthritis. Br J Rheumatol 34(2):7–15

    PubMed  Google Scholar 

  • Smith KG, Jones RB, Burns SM, Jayne DR (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum 54:2970–2982

    Article  CAS  PubMed  Google Scholar 

  • Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355:1018–1028

    Article  CAS  PubMed  Google Scholar 

  • Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, David CS (2002) CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 168:5867–5875

    CAS  PubMed  Google Scholar 

  • Thomas R, McIlraith M, Davis LS, Lipsky PE (1992) Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum 35:1455–1465

    Article  CAS  PubMed  Google Scholar 

  • Tsubaki T, Takegawa S, Hanamoto H, Arita N, Kamogawa J, Yamamoto H, Takubo N, Nakata S, Yamada K, Yamamoto S, Yoshie O, Nose M (2005) Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin Exp Immunol 141:363–371

    Article  CAS  PubMed  Google Scholar 

  • Tyndall A, Saccardi R (2005) Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 141:1–9

    Article  CAS  PubMed  Google Scholar 

  • Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427–430

    Article  CAS  PubMed  Google Scholar 

  • Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM (2001) IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol 2:157–164

    Article  CAS  PubMed  Google Scholar 

  • Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310–1316

    Article  CAS  PubMed  Google Scholar 

  • Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164:2832–2838

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Deutsches Rheuma-Forschungszentrum Berlin, Chariteplatz 1, 10117, Berlin, Germany

    U. Niesner & I. Albrecht

  2. Deutsches Rheuma-Forschungszentrum Berlin, Schumannstr. 21/22, 10117, Berlin, Germany

    A. Radbruch

Authors
  1. U. Niesner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Albrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Radbruch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Radbruch .

Editor information

A. Radbruch H.-D. Volk K. Asadullah W.-D. Doecke

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag

About this paper

Cite this paper

Niesner, U., Albrecht, I., Radbruch, A. (2007). Targeting of Memory. In: Radbruch, A., Volk, HD., Asadullah, K., Doecke, WD. (eds) Immunotherapy in 2020. Ernst Schering Foundation Symposium Proceedings, vol 2006/4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/2789_2007_037

Download citation

  • DOI: https://doi.org/10.1007/2789_2007_037

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-70850-6

  • Online ISBN: 978-3-540-70851-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation